Miguel Pereira-Silva holds a Master's Degree in Pharmaceutical Sciences (2017) and Postgraduate Studies in Pharmaceutical Biotechnology (2019), from the Faculty of Pharmacy, University of Coimbra (FFUC). Miguel is interested in advanced biomimetic nanosystems for improved pancreatic cancer-targeted therapies and is currently a Ph.D. student in Pharmaceutical Technology at FFUC and Faculty of Pharmacy, University of Santiago de Compostela, since 2019. Miguel participated in the project "Novel therapeutic strategy for osteosarcoma combining polyplexes and polymeric micelles" as a research fellow (2018-2019), FFUC and has authored/co-authored over 21 articles in peer-reviewed international journals of the field (h-index 13,>360 citations).
Representative Publications
Micelleplex-based nucleic acid therapeutics: From targeted stimuli-responsiveness to nanotoxicity and regulation
10.1016/j.ejps.2020.105461
Nanomedicine in osteosarcoma therapy: Micelleplexes for delivery of nucleic acids and drugs toward osteosarcoma-targeted therapies
10.1016/j.ejpb.2019.10.013
Nanotechnology-based formulations for resveratrol delivery: effects on resveratrol in vivo bioavailability and bioactivity
10.1016/j.colsurfb.2019.04.030
Evolution of hair treatment and care: prospects of nanotube-based formulations
10.3390/nano9060903
